Evidence map›Paper›PMID 34867947›Full record

ArticleFrontiers in immunology2021

Cellular and Molecular Phenotypes of pConsensus Peptide (pCons) Induced CD8

Ram P Singh, Bevra H Hahn, David S Bischoff

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Peptide-based immunotherapy in lupus: Where are we now?Rheumatology and immunology research · 2023
    Review
  4. CD4BMC biology · 2023
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ram P SinghResearch Service, Veteran Administration Greater Los Angeles Healthcare System, Los Angeles, CA, United States.
Bevra H HahnDivision of Rheumatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.
David S BischoffResearch Service, Veteran Administration Greater Los Angeles Healthcare System, Los Angeles, CA, United States.
VA Greater Los Angeles Healthcare System · USUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with widespread inflammation, immune dysregulation, and is associated with the generation of destructive anti-DNA autoantibodies. We have shown previously the immune modulatory properties of pCons peptide in the induction of both CD4

Indexed as

AdultAgedAmino Acid SequenceAnimalsAntigens, Differentiation, T-LymphocyteApoptosisCD8-Positive T-LymphocytesDisease Models, AnimalEpitopes, T-LymphocyteFemaleGene ExpressionHealthy VolunteersHumansImmune ToleranceLupus Erythematosus, SystemicMiceAntigens, Differentiation, T-LymphocyteEpitopes, T-LymphocytePeptidesRGS Proteinsanti-DNA Abimmune regulationimmune tolerancepConsregulatory T cellssystemic lupus erythematosus

Identifiers

PMID34867947
PMCPMC8640085
OpenAlexW3215336214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.